Vanderbilt Health researchers have isolated potent anti-measles antibodies that will soon be used in clinical testing, according to Vanderbilt Health News.

James Crowe measles

James Crowe Jr., director of the Vanderbilt Center for Antibody Therapeutics

California-based company Saravir Biopharma has licensed the antibodies to further development and clinical testing after the antibodies neutralized the measles virus in the laboratory at Vanderbilt (read more here).